Financial News
Articles published by LEO Pharma
![](https://mms.businesswire.com/media/20240821853809/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20240725413549/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20240718072831/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20240507292614/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20240503809381/en/2118604/22/Leo_Pharma_Q1_2024.jpg)
![](https://mms.businesswire.com/media/20240310740543/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20240306040005/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20240229848416/en/662919/5/leopharma.jpg)
Annual Report 2023: LEO Pharma Delivers 10% Revenue Growth and Returns to Positive EBITDA
February 29, 2024
From LEO Pharma
Via Business Wire
![](https://mms.businesswire.com/media/20240123989016/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20240123892208/en/662919/5/leopharma.jpg)
From LEO Pharma
Via Business Wire
![](https://mms.businesswire.com/media/20231215374551/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20231030388942/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20231013784653/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20231013138658/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20231011683203/en/662919/5/leopharma.jpg)
Temtokibart achieves First Subject First Treatment (FSFT) milestone in Phase 2b trial
October 11, 2023
From LEO Pharma
Via Business Wire
![](https://mms.businesswire.com/media/20231009559233/en/662919/5/leopharma.jpg)
Globally Known Professor and Dermatologist Joins LEO Pharma
October 09, 2023
From LEO Pharma
Via Business Wire
![](https://mms.businesswire.com/media/20230912301371/en/662919/5/leopharma.jpg)
LEO Pharma delivers solid first half-year results and strengthens its capital structure
September 12, 2023
From LEO Pharma
Via Business Wire
![](https://mms.businesswire.com/media/20230828609120/en/662919/5/leopharma.jpg)
LEO Pharma announces changes to its Global Leadership Team
August 28, 2023
From LEO Pharma
Via Business Wire
![](https://mms.businesswire.com/media/20230821413550/en/662919/5/leopharma.jpg)
LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals
August 21, 2023
From LEO Pharma
Via Business Wire
![](https://mms.businesswire.com/media/20230817014758/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20230318005014/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20230318005013/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20230317005158/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20230314005699/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20230310005162/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20230209005440/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20221205005373/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20221002005013/en/662919/5/leopharma.jpg)
![](https://mms.businesswire.com/media/20220928005502/en/662919/5/leopharma.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.